BCM conducts the first scientific studies to assess the potential therapeutic effects of CBD

Cannabidiol or CBD, a non-addictive product derived from hemp (cannabis), is rapidly increasing in popularity due to its anecdotal health benefits for a variety of conditions, from reducing anxiety to helping with movement disorders.

In 2019, Medterra CBD approached Dr. Mathew Halpert, research faculty in the Department of Pathology and Immunology at Baylor College of Medicine, to conduct independent scientific studies to determine the biological capabilities of several of its products.

“About a year later we have the results of the first scientific studies that assess the potential therapeutic effects of CBD for arthritic pain in dogs, and the results could lead the way to studying its effect in humans,” Halpert said.

Halpert and his colleagues focused first on dogs because their condition closely mimics the characteristics of human arthritis, the leading cause of pain and disability in the U.S. for which there is no effective treatment.


Leave a Reply